Get started
Author

Jacqueline Mock

Observed names: J Mock, J. Mock, J.C. Mock, Jaqueline Mock, Mock, Jacqueline, Mock, Jacqueline Caroline
ORCID: 0000-0002-4618-1113
Observed ORCID: 0000-0002-4618-1113
OpenAlex ID: A5006045158
An ultra-high-affinity small organic ligand of fibroblast activation protein for tumor-targeting applications
2021 · Jacopo Millul, Gabriele Bassi, et al. · Proceedings of the National Academy of Sciences · 166
Translational imaging of the fibroblast activation protein (FAP) using the new ligand [68Ga]Ga-OncoFAP-DOTAGA
2021 · P. Backhaus, F. Gierse, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 112
PDF
A Dimeric FAP-Targeting Small-Molecule Radioconjugate with High and Prolonged Tumor Uptake
2022 · Andrea Galbiati, Aureliano Zana, et al. · Journal of Nuclear Medicine · 87
PDF
Cytoplasmic glycoengineering enables biosynthesis of nanoscale glycoprotein assemblies
2019 · Hanne L. P. Tytgat, Chia-wei Lin, et al. · Nature Communications · 49
PDF
Preclinical Evaluation of 177 Lu-OncoFAP-23, a Multivalent FAP-Targeted Radiopharmaceutical Therapeutic for Solid Tumors
2024 · Andrea Galbiati, Matilde Bocci, et al. · Journal of Nuclear Medicine · 44
PDF
Small Organic Carbonic Anhydrase IX Ligands from DNA-Encoded Chemical Libraries for Tumor-Targeted Delivery of Radionuclides
2025 · Marco Müller, Tony Georgiev, et al. · Journal of the American Chemical Society · 28
An engineered 4-1BBL fusion protein with “activity on demand”
2020 · Jacqueline Mock, Marco Stringhini, et al. · Proceedings of the National Academy of Sciences · 27
PDF
A Novel Antibody–IL15 Fusion Protein Selectively Localizes to Tumors, Synergizes with TNF-based Immunocytokine, and Inhibits Metastasis
2021 · Riccardo Corbellari, Marco Stringhini, et al. · Molecular Cancer Therapeutics · 22
A universal reporter cell line for bioactivity evaluation of engineered cytokine products
2020 · Jacqueline Mock, Christian Pellegrino, et al. · Scientific Reports · 19
PDF
Tumor-Targeted Interleukin 2 Boosts the Anticancer Activity of FAP-Directed Radioligand Therapeutics
2023 · Andrea Galbiati, Paulina Dorten, et al. · Journal of Nuclear Medicine · 18
PDF
An Attenuated Targeted-TNF Localizes to Tumors In Vivo and Regains Activity at the Site of Disease
2021 · Sheila Dakhel, Christian Lizak, et al. · International Journal of Molecular Sciences · 17
PDF
Translational and First-in-Human Positron Emission Tomography Targeting Prostatic Acid Phosphatase in Prostate Cancer Using the Ligand [68Ga]Ga-OncoACP3-DOTA
2025 · Philipp Backhaus, Samuele Cazzamalli, et al. · European Urology · 15
A single‐chain variable fragment‐based bispecific T‐cell activating antibody against CD117 enables T‐cell mediated lysis of acute myeloid leukemia and hematopoietic stem and progenitor cells
2024 · Laura Volta, Renier Myburgh, et al. · HemaSphere · 13
PDF
Cancer therapy in mice using a pure population of CD8+ T cell specific to the AH1 tumor rejection antigen
2021 · Marco Stringhini, Ilaria Spadafora, et al. · Cancer Immunology Immunotherapy · 12
PDF
A novel strategy to generate immunocytokines with activity-on-demand using small molecule inhibitors
2024 · Giulia Rotta, Ettore Gilardoni, et al. · EMBO Molecular Medicine · 10
PDF
Generation of a novel fully human non-superagonistic anti-CD28 antibody with efficient and safe T-cell co-stimulation properties
2023 · Abdullah Elsayed, Christian Pellegrino, et al. · mAbs · 9
PDF
An Engineered IFNγ-Antibody Fusion Protein with Improved Tumor-Homing Properties
2023 · Cesare Di Nitto, Ettore Gilardoni, et al. · Pharmaceutics · 8
PDF
Targeting an engineered cytokine with interleukin-2 and interleukin-15 activity to the neovasculature of solid tumors
2020 · Michael R. Mortensen, Jacqueline Mock, et al. · Oncotarget · 7
Antibody-mediated delivery of LIGHT to the tumor boosts natural killer cells and delays tumor progression
2021 · Marco Stringhini, Jacqueline Mock, et al. · mAbs · 5
A Bispecific Antibody Targeting CD117 and CD3 Enables T Cell Mediated Killing of CD117-Expressing Healthy and Malignant Hematopoietic Cells
2021 · Jonathan D Kiefer, Renier Myburgh, et al. · Blood · 4
Safety, dosimetry and preliminary imaging findings of [68Ga]Ga-OncoFAP – a prospective multicenter Phase I clinical trial
2025 · Margarita Kirienko, Martina Sollini, et al. · The EANM Journal · 3
1037P Phase I dose-escalation trial with tumor-targeted interleukin-12 (IL12-L19L19) in patients with solid tumors
2023 · N. Mach, C. Belli, et al. · Annals of Oncology · 3
PDF
26O Phase I dose-escalation trial with tumor-targeted interleukin-12 (IL12-L19L19) in patients with solid tumors
2024 · G. Curigliano, C. Belli, et al. · ESMO Open · 2
Abstract 5744: Decreasing toxicity of immunocytokines by transient and selective inhibition of their intracellular signaling activation
2023 · Giulia Rotta, Ettore Gilardoni, et al. · Cancer Research · 2
[68Ga]Ga-OncoACP3 PET imaging defines acid phosphatase 3 as a clinically actionable theranostic target in prostate cancer: a prospective phase I trial
2026 · Martina Sollini, Fabrizia Gelardi, et al. · The EANM Journal · 1
Works count: 40
Citation count: 688
H-index: 13
I10-index: 15
Year
Topic
Type